FDA NDC Directory · JSON-LD · Markdown

OGIVRI

NDC 67457-847 · HUMAN PRESCRIPTION DRUG · KIT

Generic nametrastuzumab
Labeler / ManufacturerMylan Institutional LLC
Marketing categoryBiologic License Application · App BLA761074
Dosage form / routeKIT
Active ingredients—
Marketing started20191129
Marketing ended20270430
Package count1

External sources

Source: openFDA. Public-domain (CC0).